E-DRUG Archives (by thread)

  • [e-drug] Magnesium sulphate for pre-eclampsia, Beverley Snell
  • [e-drug] Antibiotic use study, Beverley Snell
  • [e-drug] Kenya: guidelines to end inappropriate use of painkillers, Kirsten Myhr
  • [e-drug] Disclosure of info as foundation for developing new medicines, Jsavirimuthu
  • [e-drug] Zimbabwe anti-retroviral patents page, WilbertBannenberg
  • [e-drug] Re: Cryptosporidiosis, Jsavirimuthu
  • [e-drug] MSF/HealthGAP meeting in Barcelona, julia_double
  • [e-drug] new WHO/EDM Executive Director, e-drug
  • [e-drug] MSH-Bill Gates Foundation Essential Medicines Franchise, Trouiller, Patrice
  • [e-drug] Re: MSH-Bill Gates Foundation Essential Medicines Franchise, Beverley Snell
  • [e-drug] Re: MSH-Bill Gates Foundation Essential Medicines Franchise (cont), David Henry
  • [e-drug] Zimbabwe HIV emergency, Beverley Snell
  • [e-drug] Evergreening of patents, Kirsten Myhr
  • [e-drug] Re: Evergreening of patents, Jsavirimuthu
  • [e-drug] Re: Evergreening of patents (cont), Barbara Mintzes
  • [e-drug] Re: NYT: New Drug for Malaria Pits U.S. Against Africa, Kibumba George
  • [e-drug] Handheld computers in resource-poor settings, Leela McCullough
  • [e-drug] Quality use of Medicines in Australia, Libby Roughead
  • [e-drug] International Clinical Pharmacy Symposium Malaysia, snling
  • [e-drug] Clinical Pharmacy Conference in Malaysia 22-23 July, snling
  • [e-drug] Re: Handheld computers in resource-poor settings, Jon Rohde
  • [e-drug] Re: Quality use of Medicines in Australia, Ken Harvey
  • [e-drug] Re: Handheld computers in resource-poor settings (cont), Bonnie Fundafunda
  • [e-drug] New body to oversee clinical trial ethics in developing world, sfoster
  • [e-drug] Re: New body [....] clinical trial ethics in developing world, Frank Webb
  • [e-drug] Iatrogenic HIV in Africa, Hilbrand Haak
  • [e-drug] EU and TRIPS, Jsavirimuthu
  • [e-drug] Course: Managing Drug Supply for Primary Health Care, Miralles,Maria
  • [e-drug] Re: Pharmaceutical Innovation in a Global Economy, Nancy Blum
  • [e-drug] Re: Iatrogenic HIV in Africa, Trouiller, Patrice
  • [e-drug] Promoting Rational Drug Use in the Community (PRDUC), hogerzeilh
  • [e-drug] Conflict of Interest?, Sidney Wolfe
  • [e-drug] Re: Conflict of Interest?, Dr.L.Offerhaus
  • [e-drug] UK consumers reject direct advertising by drug industry, E-drug
  • [e-drug] Re: Quality use of Medicines in Australia (cont), Joel Lexchin
  • [e-drug] Re: Conflict of Interest? (cont), Jon Rohde
  • [e-drug] New ORS formulation, Beverley Snell
  • [e-drug] A Whistle-Blower Rocks an Industry, Sidney Wolfe
  • [e-drug] Pfizer sues to block generic Diflucan, e-drug
  • [e-drug] WTO chief targets multinationals, e-drug
  • [e-drug] BMJ: Breast is still best even when HIV prevalence is high, e-drug
  • [e-drug] Drug development for neglected diseases, e-drug
  • [e-drug] Dutch gov't may stop monitoring advertising & marketing activities, lisa
  • [e-drug] NYTimes: U.S. Backs New Trade Rules on Drugs, e-drug
  • [e-drug] Petition EU Directive/la revue Prescrire, Christophe Kopp
  • [e-drug] US framework to increase access, e-drug
  • [e-drug] MSF's article in Le Monde on post Doha, Pierre CHIRAC
  • [e-drug] Important paper on Doha Declaration, Pascale_BOULET
  • [e-drug] Sources and prices of HIV/AIDS drugs and diagnostics, e-drug
  • [e-drug] Satellite Financing Care for PLWH, 6 July Barcelona, Renaud-Thery, Francoise
  • [e-drug] Where is the 10 billion dollars?, Act Up-Paris
  • [e-drug] G8 & global health crises: press release, relliott
  • [e-drug] Re: Sources and prices of HIV/AIDS drugs and diagnostics, Mary Ojoo
  • [e-drug] Imports of generics in francophone Africa, catherinegavin
  • [e-drug] Street vending of drugs in Africa, richardl
  • [e-drug] Antidepressants and 'miracle drug' label, E-drug
    • Mail converted by MHonArc 2.6.8